Phase 3 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a specific type of blood cancer called diffuse large B-cell lymphoma, or a slow-growing B-cell lymphoma that has recently changed into a faster-growing type
- You have either not yet started treatment, or have received no more than 2 cycles of chemotherapy (confirm with trial site)
- You are 65 years of age or older
- Your doctor has confirmed you are suitable for a chemotherapy treatment called R-CHOP
- You are generally able to carry out daily activities with minimal limitations (your doctor will assess this)
- You are enrolled in a social security or health insurance scheme
- You are willing and able to give written consent to take part in the study
Who may not be able to join:
- You have a different type of lymphoma, such as T-cell lymphoma, Burkitt's lymphoma, or a slow-growing B-cell lymphoma that has not transformed
- The lymphoma has spread to your brain or the fluid around your brain or spine
- You have a physical disability (movement or sensation) that would prevent you from taking part in adapted physical activity sessions
- You have high blood pressure that is not currently under control
- You have serious heart or breathing problems that would prevent you from taking part in physical activity sessions
- You have a significant condition affecting your bones, joints, or muscles
- Your heart pumping function is below a certain level, as measured by a heart scan (confirm with trial site)
- You have already received 3 or more cycles of first-line chemotherapy
- You are pregnant or breastfeeding
- You have an active infection of hepatitis B, hepatitis C, or HIV
- You are under legal guardianship or have had your freedom restricted
- You have dementia, a significant mental health condition, or a psychiatric illness that could affect your ability to consent or follow the study
- You are unable to follow the study requirements for personal, social, family, or location-related reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Katell LE DÛ, MD, Clinique Victor Hugo/Centre Jean Bernard
Phone: 0241682940
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To detect an absolute difference of 15% in event-free survival between the 2 groups
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.